HSG

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Wuxi Gongwang inductive sensor developer offering high-precision, oil and dust-resistant products for various industries, including aerospace, automotive, medical care, and more.

Taiyi Guanjia is a company that combines technology and medical health innovation, aiming to enhance the insurance industry and create a robust medical and health ecosystem.

Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Founded in 2012, Vivolight is a medical device company incubated and supported by Xi'an Institute of Optics and Precision Mechanics of Chinese Academy of Sciences. We are headquartered in Shenzhen and have established an R&D center in Xi’an. Rooted in the field of medical laser technology, we are committed to the independent development, global innovation and independent manufacturing of medical devices used for minimally invasive interventional diagnosis and treatment with the technology of laser by leveraging the world-leading photoelectric technology and combining medicine and engineering. In April 2020, our self-developed optical coherence tomography (OCT) system obtained the approval of NMPA and achieved commercialization. In December 2021, our innovative Multimodality OCT System was approved by NMPA. It is the first Multimodality OCT System in the field of coronary artery OCT that has been approved for clinical application. In the field of interventional laser therapy, we have multiple products that have entered the phase of pre-clinical study.

EagleChip is a chip design company that specializes in the development and design of Field Programmable Gate Arrays (FPGAs). It focuses on research and development, creating tailored electronic design automation (EDA) toolchains that cater to various industries. These industries include communications, data centers, industrial control, consumer electronics, smart vehicles, video processing, and medical electronics. EagleChip aims to provide high-quality FPGA chip solutions to meet the specific needs of its customers, ensuring a reliable domestic supply in the competitive semiconductor market.

Spectrum Medical is a clinical mass spectrometry product platform that promotes clinical mass spectrometry detection technology to the general public. It has an experienced research and development, operations, and sales team, a standardized GMP production workshop, extensive experience in laboratory construction, and a mature laboratory management system. It provides with complete supporting kits in addition to mastering the core mass spectrometry hardware manufacturing technology and equipment integration development capabilities (maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, etc.).

Scientech Medical engages in the research, development, and manufacturing of interventional medical devices.

SceneRay Co. Ltd, based in Singapore Industrial Park, Suzhou, China, specializes in the design, development, and distribution of neuromodulation devices, particularly focusing on brain pacemakers. The company’s core team comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, both in China and internationally. SceneRay's product offerings include a dual-channel implantable pulse generator kit designed for deep brain stimulation, which provides therapeutic electric stimulation to address issues related to brain damage. Committed to innovation, SceneRay holds numerous patents and strives to deliver high-quality, effective treatments for patients.

SyMap Medical focuses on developing and manufacturing a proprietary catheter-based system for renal mapping and ablation, specifically aimed at treating hypertension and various other serious conditions, including heart failure, arrhythmia, and renal failure. The company's core technology platform is based on radiofrequency (RF) ablation, which is integral to its approach in renal nerve mapping and selective ablation. This innovative medical device is designed to enhance treatment options for patients suffering from these significant health issues.

Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.

Edge Medical Robotics, Inc. was founded in Longgang, Shenzhen, China on May 4, 2017. It is committed to researching and promoting most advanced smart equipment in the world，polishing the ultimate product with the spirit of pursuing excellence and fineness, improving surgical safety and treatment efficacy, and contributing to uprising the level of social health.

Suzhou Xinqing Medical Technology Co., Ltd., founded in 2017 by Dr. Xu Bozhen, focuses on the development of in-vitro artificial heart devices aimed at assisting patients with cardiovascular illnesses. The company specializes in creating short-term to medium-term ventricular assist devices that leverage advanced fluid mechanics and magnetic suspension technology. These innovations allow the devices to be compatible with various blood types, thereby reducing the risk of incompatibility for patients. With a team of leading experts in artificial heart engineering, the company has successfully developed an artificial heart that holds independent intellectual property rights, positioning itself as a key player in the medical technology sector.

Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.

Geneus develops and commercializes gene sequencers and reagents. The core of its technology is based on the characteristic current signal generated by the interaction of protein nanopores and nucleic acid bases, and it realizes single-molecule nucleic acid sequencing through an integrated chip system.

Huayuan Regenerative Medicine is the manufacture of implantable bioartificial organs. Huayuan Regenerative Medicine is committed to the research and development, production, and sales of clinical grade stem cells, biological tissue engineering products, and biomanufacturing. Their clinical products include urinary kidney precursor cells, dialysis equipment, and a biosynthetic artificial pancreas.

Benchling, Inc. is a developer of a cloud-based informatics platform tailored for life sciences research and development. The platform includes a suite of integrated applications that allow scientists to design, share, and document experiments, as well as manage biological entities like plasmids and antibodies. Key features include Benchling Insights, which enables users to visualize and collaborate on structured data, and a biological registration system for inventory tracking. Benchling's solutions cater to a diverse range of applications such as gene therapy, vaccines, and industrial biotechnology, serving scientists in biotech, pharmaceutical, academic, and government sectors. Established in 2012 and based in San Francisco, the company aims to enhance the speed and collaboration of life science research by providing tools that streamline workflows and facilitate critical R&D decisions.

PackGene Biotech, LLC is a biotechnology company based in the United States that specializes in developing viral vectors for gene therapies. It primarily focuses on adeno-associated virus (AAV) vectors, offering comprehensive services that include vector design, cloning, and packaging. The company also provides solutions for mRNA, plasmid DNA, and lentiviral vectors. With an emphasis on early-stage drug discovery and preclinical development, PackGene Biotech supports researchers in the medical industry by delivering high-purity, high-titer, and high-infectivity vectors for clinical applications. Its capabilities enable scalable and cost-effective production, facilitating advancements in cell and gene therapy trials.

Neuracle is a prominent enterprise in China's neuroscience sector, specializing in neural monitoring and diagnostic technology. Leveraging advanced brain-machine interface technology developed in collaboration with Tsinghua University, Neuracle focuses on innovative research across neuroscience, psychology, and neuroengineering. The company provides comprehensive solutions for the diagnosis, treatment, and rehabilitation of clinical neurological diseases. Its product offerings include digital electroencephalographs that allow healthcare institutions to monitor patients' brain bioelectricity levels and facilitate accurate diagnoses of neural conditions. Neuracle's contributions span various fields, including clinical medicine and management marketing, and the company's research and development efforts have garnered recognition from experts in neuroscience and clinical medicine both domestically and internationally.

Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.

Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.

Insight Lifetech is a medical technology company focused on creating innovative solutions for the diagnosis and treatment of cardiovascular diseases. It has developed a synergistic platform that integrates research and development, manufacturing, and commercialization, which enhances collaboration, accelerates product development, and promotes cost efficiency. The company is notable for creating the first and only domestic fractional flow reserve (FFR) system in China that has received approval from the National Medical Products Administration (NMPA). By manufacturing high-quality medical devices that feature reliable precision diagnostics and therapeutic capabilities, Insight Lifetech aims to empower physicians to improve patient outcomes and save lives.

AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.

Medtrum is a company focused on simplifying diabetes management through the development and marketing of medical devices and related software. Their products are designed to help patients with various types of diabetes monitor and manage their glucose levels and insulin pump status effectively. Additionally, Medtrum aims to enhance the convenience of healthcare for professionals while exploring advancements in artificial pancreas research.

Farcast Biosciences is a clinical diagnostic company focused on improving cancer treatment through personalized medicine. Founded in 2019 and based in Madison, Wisconsin, with a laboratory in Bangalore, India, Farcast has developed a human tumor microenvironment platform. This platform allows oncologists and drug developers to evaluate individual tumors by culturing fresh, unmodified tumor fragments, preserving their natural state. By generating detailed response data, Farcast's technology aids in identifying optimal treatment options for patients before they begin therapy. This approach not only enhances the understanding of tumor behavior but also supports researchers in drug development by providing insights into treatment responses using real human tumors and blood samples.

Whale Imaging Inc. manufactures medical imaging devices, specializing in surgical imaging systems and ultrasound systems. Its product line includes G-Arm products, such as the G-Arm B6 Duo and G-Arm GXi 2, as well as portable ultrasound devices like the Lambda P9 and Sigma P5. In addition to manufacturing, Whale Imaging offers training, preventative maintenance, and support services to ensure optimal use of its products. Founded in 1998, the company is headquartered in Beijing's hi-tech enterprise zone, with research and development facilities being established in Boston, Massachusetts. Whale Imaging underwent a strategic revitalization in 2008 under the leadership of Sean Zhu.

Whale is a manufacturer specializing in multi-planar surgical imaging and portable diagnostic ultrasound products. The company develops imaging devices that utilize proprietary technologies and advanced manufacturing methods to create safe and efficient systems. These products are designed to enhance the capabilities of surgeons, allowing them to perform procedures with increased speed and ease. By focusing on innovation and user-friendly design, Whale aims to improve surgical outcomes and streamline diagnostic processes in the medical field.

Angel Medical (China) Holdings Group is a commitment to high-quality medical resources in China integration and brand management Investment Group, which is headquartered in Chengdu, China. Angel Medical (China) Holdings implementation of the "scale, brand, chain, professional" development strategy, by gradually expanding the range of services and investment, investment in a wide range of interventional medical field, to carry out high-end medical service-oriented industry, finance-related industry as a whole, diversified regional healthcare brand chain operations. Angel Medical (China) Holdings Group's high-end maternity hospital "Angel Maternity Hospital in Chengdu," has achieved the industry, government and social identity. Was "an example of well-known Chinese brand maternity hospital in 2009," the most prestigious award, the formation of a good brand, reputation. Hospital through the International Joint Commission established by the U.S. Department of JCI (Joint Commission International Accreditation Standards for Hospital) certification, awarded China the first 15, the southwest region's first and only international Chengdu, Sichuan JCI certified hospitals. Hospitals adhere to the "integrity, quality, pioneering and enterprising," the purpose of running the hospitals, medical treatment, research, prevention, care and rehabilitation as one of the maternity hospital. Now docking with the international capital and listing platform to build has been completed. Angel Medical (China) Holdings Group has a modern management team, experienced professional team of physicians, as well as a strong operations team. Group advanced medical management philosophy, according to the prevailing business model of international medical institutions, construction and management standards, building health care environment, good health care forms, and constantly open up the health care market in mainland China.

ASG Eye Hospitals is a chain of super-specialty eye hospitals operating in various cities across India, including regions in North and North East India, as well as states like Rajasthan, Uttar Pradesh, and Madhya Pradesh. Founded by ophthalmology experts from AIIMS, New Delhi, the hospital network focuses on delivering comprehensive diagnosis, treatment, and surgical services for a wide array of ocular conditions. ASG Eye Hospitals specializes in treatments for cataracts, diabetic retinopathy, glaucoma, macular degeneration, and eye tumors, utilizing advanced technology to enhance patient care. The organization employs highly skilled and trained professionals, ensuring that patients receive world-class surgical expertise and care tailored to their vision needs.

Betta Pharmaceuticals Co., Ltd. is a prominent Chinese pharmaceutical company, established in 2003 and headquartered in Hangzhou. It specializes in the research, development, manufacturing, and marketing of innovative medicines aimed at treating malignant tumors, diabetes, and cardio-cerebrovascular diseases. Among its notable products is Icotinib hydrochloride, a reversible tyrosine kinase inhibitor used for non-small-cell lung cancer, which has garnered recognition for being the first targeted anti-cancer drug developed in China. Betta is actively engaged in over 20 new drug development projects and has formed strategic partnerships, including an agreement with Amgen Inc. for marketing Vectibix in China. The company prides itself on its independent intellectual property rights and has received numerous awards for its contributions to pharmaceutical innovation, including multiple national science and technology prizes. With a workforce nearing 1,000 employees, including a team of highly educated professionals, Betta Pharmaceuticals is dedicated to enhancing public health through the development of high-quality, affordable medications.

EndoSpan Ltd., established in 2008 and headquartered in Herzliya, Israel, specializes in the design and development of innovative stent graft systems under the brand name NEXUS. The company focuses on minimally invasive endovascular repair solutions for aortic arch diseases, including aneurysms and dissections. Its portfolio includes the Endo-Vascular Aortic Aneurysm Repair (EVAR) system, which is tailored for both unilateral and percutaneous approaches. By offering differentiated aortic endografts, EndoSpan aims to address the specific needs of patients with aortic lesions, providing effective treatment options in an underserved clinical area. The company is currently in the pre-clinical stage of development and is backed by venture capital.

Hinacom Software and Technology, Ltd. is a healthcare IT company specializing in medical imaging and information management solutions. Based in Beijing, China, the company offers its miPlatform, an integrated medical imaging suite that encompasses various components such as Enterprise PACS/RIS, Regional PACS, TeleMed/TeleRad, web-based 3D processing, clinical image-based conferencing, and mobile imaging systems. The Enterprise PACS/RIS system is designed with a browser/server architecture to enhance workflow management, while the Regional PACS system facilitates patient-centered collaboration for medical imaging services across multiple hospitals in a region. The TeleMed/TeleRad system enables image transmission, viewing, and conferencing within web environments. Hinacom's solutions are utilized by hospitals and teleradiology projects in China, as well as by radiologists and clinicians in the United States, Europe, and Southeast Asia. Founded in 2008, the company has established itself as a key player in the medical imaging industry.

Celon Laboratories Limited is a pharmaceutical company based in Hyderabad, India, focused on developing, manufacturing, and marketing products primarily in oncology, anti-infective, and critical care markets. The company produces a range of dosage forms, including un-coated and coated tablets, capsules, ampoules, vials, pre-filled syringes, and emulsion injections. Celon Laboratories also offers contract research manufacturing services, which encompass formulation development, lyophilization cycle development, quality control testing, stability studies, and regulatory support. Its products and services cater to a diverse clientele across the Asia Pacific, Africa, Latin America, CIS countries, and Eastern Europe. Established in 2001, the company is dedicated to providing innovative drug delivery systems and quality formulations to enhance patient treatment outcomes.